The risk of
other primary cancer in patients with uveal melanoma: a retrospective
cohort study of a Canadian population
S.A. Callejo, S. Al-Khalifa, P.Ç.
Özdal, C. Edelstein, M.N. Burnier, Jr. ABSTRACT
Background:
The incidence of second primary malignant
tumours has doubled during the last 2 decades. These tumours now represent
the sixth most common group of cancers. Many authors have described
the presence of multiple primary cancers in patients with uveal melanoma.
However, no studies have been performed using Canadian data. The purpose
of this study was to describe the occurrence of other primary cancers
diagnosed before or after uveal melanoma and to calculate the incidence
of subsequent primary cancer in a Canadian cohort with uveal melanoma.
Methods:
We conducted a retrospective study of
a cohort of patients with uveal melanoma diagnosed between 1990 and
2002 at a university-affiliated centre in Montreal. We reviewed medical
records to identify patients in whom other, unrelated primary malignant
disease had been diagnosed. We used the standardized incidence ratio
to calculate the risk of development of a second, unrelated cancer following
the diagnosis of uveal melanoma.
Results:
A total of 129 cases of uveal melanoma
were diagnosed. Eighteen patients (14%) also had a diagnosis of an unrelated
primary cancer. In nine patients the other cancer had been diagnosed
first, and in nine patients the other tumour had been diagnosed after
the uveal melanoma. There was no increased risk of development of any
particular form of cancer studied for females or males.
Interpretation:
In our Canadian cohort, statistical
analysis showed no increased risk of a second cancer, overall or by
organ site, in male or female patients with uveal melanoma. As uveal
melanoma is a rare type of cancer, analyses of a much larger cohort
may be needed to accurately estimate the risk of development of a second
primary cancer in patients with uveal melanoma.
|